61
55
Growth Score
-15 pts
Heat Score
0 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
282876
AAVnerGene develops gene therapy technologies using the AAV platform, focusing on AAV production and capsid engineering.
- Daozhan Yu: Founder, President and CEO
About the Company
AAVnerGene specializes in the development of gene therapy technologies using the AAV platform. The company focuses on AAV production, libraries, capsid engineering, and gene therapy. AAVnerGene's AAVtri System includes a mini-pHelper plasmid to replace the original pHelper plasmid. Their pAAVone series evaluates the productivity of their novel
AAVone production system for various transgene sizes. The company collaborates with partners like Neurophth Therapeutics to advance gene therapy solutions.
